Subtopic Deep Dive

← Pharmacovigilance and Adverse Drug Reactions

Patient Reporting in Pharmacovigilance
Research Guide

What is Patient Reporting in Pharmacovigilance?

Patient reporting in pharmacovigilance refers to direct submissions of adverse drug reaction experiences by patients to regulatory databases, complementing healthcare professional reports.

Patients report unique details on event severity, onset, and narratives not captured in professional reports. Over 1800 citations in Hazell and Shakir (2006) highlight under-reporting issues addressed partly by patient inputs. Sakaeda et al. (2013) analyzed FDA's FAERS database, which accepts patient reports alongside manufacturer and professional submissions (882 citations).

Curated Papers

Key Challenges

Why It Matters

Patient reports enrich pharmacovigilance by identifying underreported events and diverse perspectives, reducing gaps in FAERS data as shown in Sakaeda et al. (2013). They contribute to signal detection for post-marketing surveillance, with Hazell and Shakir (2006) estimating significant under-reporting that patient inputs mitigate. Pirmohamed et al. (2004) found ADRs cause 6.5% of hospital admissions, underscoring how patient narratives enhance causality assessment and regulatory actions (3166 citations).

Key Research Challenges

Under-reporting by Patients

Patients under-report ADRs due to lack of awareness and reporting barriers, as detailed in Hazell and Shakir (2006) with 1805 citations. This leads to incomplete databases like FAERS. Professional reports dominate, masking patient-specific insights.

Data Quality Variability

Patient narratives often lack medical precision, complicating signal detection in FAERS per Sakaeda et al. (2013). Verification of severity and causality remains challenging. Davies et al. (2009) noted similar issues in hospital ADR data (686 citations).

Integration with Professional Reports

Complementarity between patient and professional reports requires advanced mining, as in Sakaeda et al. (2013). Differences in reporting patterns hinder unified analysis. Kongkaew et al. (2008) systematic review shows methodological variances affecting prevalence estimates (626 citations).

Essential Papers

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Munir Pirmohamed, Sally James, Shaun Meakin et al. · 2004 · BMJ · 3.2K citations

Abstract Objective To ascertain the current burden of adverse drug reactions (ADRs) through a prospective analysis of all admissions to hospital. Design Prospective observational study. Setting Two...

Under-Reporting of Adverse Drug Reactions

Lorna Hazell, Saad Shakir · 2006 · Drug Safety · 1.8K citations

Data Mining of the Public Version of the FDA Adverse Event Reporting System

Toshiyuki Sakaeda, Akiko Tamon, Kaori Kadoyama et al. · 2013 · International Journal of Medical Sciences · 882 citations

The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS, formerly AERS) is a database that contains information on adverse event and medication error reports submitted to th...

Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

Emma Davies, Christopher F. Green, Stephen Taylor et al. · 2009 · PLoS ONE · 686 citations

Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. ...

Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies

Chuenjid Kongkaew, Peter Noyce, Darren M. Ashcroft · 2008 · Annals of Pharmacotherapy · 626 citations

Objective: To determine the prevalence of hospital admissions associated with ADRs and examine differences in prevalence rates between population groups and methods of ADR detection. Data Sources: ...

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Igho Onakpoya, Carl J Heneghan, Jeffrey K Aronson · 2016 · BMC Medicine · 585 citations

The original article [1] contains a minor error whereby the dates for year of first launch and year of first report of adverse reaction for iophendylate in e-Appendix Table 1 are mistakenly present...

Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features

Azadeh Nikfarjam, Abeed Sarker, Karen O’Connor et al. · 2015 · Journal of the American Medical Informatics Association · 547 citations

Abstract Objective Social media is becoming increasingly popular as a platform for sharing personal health-related information. This information can be utilized for public health monitoring tasks, ...

Reading Guide

Foundational Papers

Start with Pirmohamed et al. (2004, 3166 citations) for ADR hospital burden context; Hazell and Shakir (2006, 1805 citations) for under-reporting mechanisms; Sakaeda et al. (2013, 882 citations) for FAERS patient data mining.

Recent Advances

Kongkaew et al. (2008, 626 citations) systematic review of ADR admissions; Davies et al. (2009, 686 citations) on in-patient ADRs; Nikfarjam et al. (2015, 547 citations) on social media pharmacovigilance extending patient reporting.

Core Methods

Prospective observational studies (Pirmohamed et al., 2004); FAERS data mining (Sakaeda et al., 2013); systematic reviews of prevalence (Kongkaew et al., 2008).

How PapersFlow Helps You Research Patient Reporting in Pharmacovigilance

Discover & Search

Research Agent uses searchPapers and exaSearch to find patient reporting studies in FAERS, then citationGraph on Sakaeda et al. (2013) reveals connected under-reporting analyses like Hazell and Shakir (2006). findSimilarPapers expands to digital tools for submissions.

Analyze & Verify

Analysis Agent applies readPaperContent to extract FAERS patient report patterns from Sakaeda et al. (2013), verifies ADR causality claims via verifyResponse (CoVe), and uses runPythonAnalysis for statistical comparison of reporting rates with GRADE grading for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in patient vs. professional reporting coverage, flags contradictions in under-reporting estimates, and supports Writing Agent with latexEditText for methods sections, latexSyncCitations for Pirmohamed et al. (2004), and latexCompile for full reviews; exportMermaid visualizes reporting complementarity flows.

Use Cases

"Analyze under-reporting rates in patient vs professional FAERS submissions"

Research Agent → searchPapers + exaSearch → Analysis Agent → readPaperContent (Sakaeda 2013) → runPythonAnalysis (pandas stats on rates) → CSV export of verified rates comparison.

"Write LaTeX review on barriers to patient ADR reporting"

Synthesis Agent → gap detection (Hazell 2006) → Writing Agent → latexEditText (intro) → latexSyncCitations (Pirmohamed 2004) → latexCompile → PDF with integrated bibliography.

"Find code for mining patient narratives in pharmacovigilance databases"

Research Agent → searchPapers (FAERS mining) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for sequence labeling like Nikfarjam et al. (2015).

Automated Workflows

Deep Research workflow conducts systematic review of 50+ FAERS papers: searchPapers → citationGraph → DeepScan for 7-step ADR pattern analysis with CoVe checkpoints. Theorizer generates hypotheses on patient reporting barriers from Hazell (2006) and Sakaeda (2013) literature synthesis.

Try Doxa for Patient Reporting in Pharmacovigilance Research

Frequently Asked Questions

What is patient reporting in pharmacovigilance?

Direct patient submissions of ADRs to databases like FAERS, providing narratives complementary to professional reports (Sakaeda et al., 2013).

What methods analyze patient reports?

Data mining of FAERS public versions detects signals; sequence labeling extracts mentions from narratives (Sakaeda et al., 2013; Nikfarjam et al., 2015).

What are key papers on patient reporting?

Sakaeda et al. (2013, 882 citations) on FAERS mining; Hazell and Shakir (2006, 1805 citations) on under-reporting addressed by patients; Pirmohamed et al. (2004, 3166 citations) on ADR burden.

What open problems exist?

Improving patient report quality, integrating with professional data, and reducing under-reporting barriers remain challenges (Hazell and Shakir, 2006; Kongkaew et al., 2008).